1,2,3,4-四氢-2-萘胺，CAS 登记号 2954-50-9，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 1,2,3,4-四氢-2-萘胺 的 CAS 号：2954-50-9，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
1,2,3,4-tetrahydro-2-naphthylamine · CAS 2954-50-9 · C10H13N. UNII O7A3GV2PNX.
| CAS Registry Number | 2954-50-9 |
|---|---|
| PubChem CID | 18066 |
| Molecular formula | C10H13N |
| IUPAC name | 1,2,3,4-tetrahydronaphthalen-1-amine |
| UNII (FDA) | O7A3GV2PNX |
| Molecular Weight | 147.22 |
|---|---|
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 147.104799419 |
| Monoisotopic Mass | 147.104799419 |
| Topological Polar Surface Area | 26 |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Reported hazard statements | H302 (69.5%), H314 (69.5%), H315 (30.5%), H318 (69.5%), H319 (30.5%), H335 (29.8%), H412 (69.5%) |
|---|
H302 (69.5%): Harmful if swallowed [Warning Acute toxicity, oral]
H314 (69.5%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
1,2,3,4-Tetrahydro-1-naphthylamine; 2217-40-5; 1-Aminotetralin; O7A3GV2PNX; NSC-30349; DTXSID70903059; RefChem:906619; 1-aminotetrahydronaphthalene; DTXCID00972455; 218-712-7; 1,2,3,4-tetrahydronaphthalen-1-amine; Aminotetralin; (+/-)-1-aminotetralin; 1-Amino-1,2,3,4-tetrahydro-naphthalene; MFCD00001740; 1-Amino-1,2,3,4-tetrahydronaphthalene
CAS 2954-50-9; molecular formula C10H13N; molecular weight — g/mol.
1,2,3,4-Tetrahydro-1-naphthylamine, 2217-40-5, 1-Aminotetralin, O7A3GV2PNX, NSC-30349, DTXSID70903059.
Hazard statements reported: H302, H314, H315, H318, H319.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.